Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4889)
All Articles published online
|
Publishing Process of This Article
|
Nov 27, 2013 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tziomalos K, Giampatzis V, Bouziana SD, Spanou M, Papadopoulou M, Pavlidis A, Kostaki S, Bozikas A, Savopoulos C, Hatzitolios AI. Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome. World J Hepatol 2013; 5(11): 621-626 [PMID: 24303090 DOI: 10.4254/wjh.v5.i11.621] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v5/i11/621.htm |
| Number | Citing Articles |
| 1 |
Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, Jieling Xiao, Phoebe Tay, Margaret Teng, Keng Siang Lee, Snow Yunni Lin, May Zin Myint, Benjamin Tan, Vijay K Sharma, Darren Jun Hao Tan, Wen Hui Lim, Apichat Kaewdech, Daniel Huang, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark Muthiah, Cheng Han Ng. Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals. Clinical and Molecular Hepatology 2022; 28(3): 483 doi: 10.3350/cmh.2021.0406
|
| 2 |
Ji Sun Nam, Sehee Jo, Shinae Kang, Chul Woo Ahn, Kyung Rae Kim, Jong Suk Park. Association between lipoprotein(a) and nonalcoholic fatty liver disease among Korean adults. Clinica Chimica Acta 2016; 461: 14 doi: 10.1016/j.cca.2016.07.003
|
| 3 |
Neal S. Parikh, Alexander E. Merkler, Yecheskel Schneider, Babak B. Navi, Hooman Kamel. Discharge Disposition After Stroke in Patients With Liver Disease. Stroke 2017; 48(2): 476 doi: 10.1161/STROKEAHA.116.016016
|
| 4 |
Ya-Juan Zhang, Wen-Juan Liu. Association between non-alcoholic fatty liver and acute cerebral infarction: a protocol of systematic review and meta-analysis. Medicine 2020; 99(24): e20351 doi: 10.1097/MD.0000000000020351
|
| 5 |
Rosa Lombardi, Silvia Fargion, Anna Ludovica Fracanzani. Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review. Digestive and Liver Disease 2019; 51(9): 1214 doi: 10.1016/j.dld.2019.05.015
|
| 6 |
Takahisa Mori, Kazuhiro Yoshioka, Yuhei Tanno. Non-alcoholic fatty liver disease frequency and associated factors at admission of acute stroke. Hepatology International 2022; 16(1): 81 doi: 10.1007/s12072-021-10253-z
|
| 7 |
Neal S. Parikh, Elora Basu, Mu Ji Hwang, Russel Rosenblatt, Lisa B. VanWagner, Hana I. Lim, Santosh B. Murthy, Hooman Kamel. Management of Stroke in Patients With Chronic Liver Disease: A Practical Review. Stroke 2023; 54(9): 2461 doi: 10.1161/STROKEAHA.123.043011
|
| 8 |
Konstantinos Tziomalos. Lipid-lowering agents in the management of nonalcoholic fatty liver disease. World Journal of Hepatology 2014; 6(10): 738-744 doi: 10.4254/wjh.v6.i10.738
|
| 9 |
Keyang Chen, Yuesong Pan, Xianglong Xiang, Xia Meng, Dongxiao Yao, Li Lin, Xiaokun Li, Yongjun Wang. The nonalcoholic fatty liver risk in prediction of unfavorable outcome after stroke: A nationwide registry analysis. Computers in Biology and Medicine 2023; 157: 106692 doi: 10.1016/j.compbiomed.2023.106692
|
| 10 |
Roberta Forlano, Benjamin H. Mullish, Rooshi Nathwani , Ameet Dhar, Mark R. Thursz, Pinelopi Manousou . Non-Alcoholic Fatty Liver Disease and Vascular Disease. Current Vascular Pharmacology 2020; 19(3): 269 doi: 10.2174/1570161118666200318103001
|
| 11 |
Natalia Motorna. Structural changes in liver under conditions of experimental hemorrhagic stroke. Current Issues in Pharmacy and Medical Sciences 2019; 32(2): 67 doi: 10.2478/cipms-2019-0013
|
| 12 |
M. K. Srilekha, S. N. Deepa, N. R. Shanker, M. Priya. Human Fatty Liver Volume Measurement Device Using Nano Graphene Polyvinyl Sensor. IEEE Sensors Journal 2023; 23(20): 25390 doi: 10.1109/JSEN.2023.3308769
|
| 13 |
Minyoul Baik, Hyo Suk Nam, Ji Hoe Heo, Hyung Jong Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Hye Sun Lee, Seung Up Kim, Young Dae Kim. Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack. Cerebrovascular Diseases 2020; 49(5): 474 doi: 10.1159/000510436
|
| 14 |
Graciela E. Delgado, Marcus E. Kleber, Angela P. Moissl, Babak Yazdani, Alexander Kusnik, Matthias P. Ebert, Winfried März, Bernhard K. Krämer, Alexander Lammert, Andreas Teufel. Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 321(3): G252 doi: 10.1152/ajpgi.00058.2021
|
| 15 |
Marcin Kosmalski, Sylwia Ziółkowska, Piotr Czarny, Janusz Szemraj, Tadeusz Pietras. The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. Journal of Clinical Medicine 2022; 11(5): 1375 doi: 10.3390/jcm11051375
|
| 16 |
Surasak Saokaew, Sukrit Kanchanasurakit, Kanitta Thawichai, Prommanee Duangprom, Monnapha Wannasri, Sirintip Khankham, Chayanis Kositamongkol, Nathorn Chaiyakunapruk, Pochamana Phisalprapa. Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patients. Medicine 2021; 100(5): e24557 doi: 10.1097/MD.0000000000024557
|
| 17 |
Stelina Alkagiet, Achilleas Papagiannis, Konstantinos Tziomalos. Associations between nonalcoholic fatty liver disease and ischemic stroke. World Journal of Hepatology 2018; 10(7): 474-478 doi: 10.4254/wjh.v10.i7.474
|
| 18 |
Zi-Lin Ren, Chang-Xiang Li, Chong-Yang Ma, Dan Chen, Jia-Hui Chen, Wen-Xiu Xu, Cong-Ai Chen, Fa-Feng Cheng, Xue-Qian Wang. Linking Nonalcoholic Fatty Liver Disease and Brain Disease: Focusing on Bile Acid Signaling. International Journal of Molecular Sciences 2022; 23(21): 13045 doi: 10.3390/ijms232113045
|
| 19 |
Lei Yang, Ke Gao, Rui-Juan Shi, Yu-Nan Qin, Xiao-Rui Huang, Ya-Jie Gao, Xiao-Pu Zheng. Fibrosis-4 index is closely associated with clinical outcomes in acute cardioembolic stroke patients with nonvalvular atrial fibrillation. Internal and Emergency Medicine 2023; 18(8): 2209 doi: 10.1007/s11739-023-03394-6
|
| 20 |
Alfredo Caturano, Carlo Acierno, Riccardo Nevola, Pia Clara Pafundi, Raffaele Galiero, Luca Rinaldi, Teresa Salvatore, Luigi Elio Adinolfi, Ferdinando Carlo Sasso. Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact. Processes 2021; 9(1): 135 doi: 10.3390/pr9010135
|
| 21 |
Minyoul Baik, Seung Up Kim, Hyo Suk Nam, Ji Hoe Heo, Young Dae Kim. The Paradoxical Protective Effect of Liver Steatosis on Severity and Functional Outcome of Ischemic Stroke. Frontiers in Neurology 2019; 10 doi: 10.3389/fneur.2019.00375
|
| 22 |
Claudio Tana, Stefano Ballestri, Fabrizio Ricci, Angelo Di Vincenzo, Andrea Ticinesi, Sabina Gallina, Maria Adele Giamberardino, Francesco Cipollone, Richard Sutton, Roberto Vettor, Artur Fedorowski, Tiziana Meschi. Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications. International Journal of Environmental Research and Public Health 2019; 16(17): 3104 doi: 10.3390/ijerph16173104
|
| 23 |
Richie Manikat, Mindie H. Nguyen. Nonalcoholic fatty liver disease and non-liver comorbidities. Clinical and Molecular Hepatology 2023; 29(Suppl): s86 doi: 10.3350/cmh.2022.0442
|
| 24 |
M. Papagianni, K. Tziomalos. Non‐alcoholic fatty liver disease: an emerging predictor of stroke risk, severity and outcome. European Journal of Neurology 2018; 25(4): 610 doi: 10.1111/ene.13584
|
| 25 |
H. Li, B. Hu, L. Wei, L. Zhou, L. Zhang, Y. Lin, B. Qin, Y. Dai, Z. Lu. Non‐alcoholic fatty liver disease is associated with stroke severity and progression of brainstem infarctions. European Journal of Neurology 2018; 25(3): 577 doi: 10.1111/ene.13556
|
| 26 |
Mauricio Montemezzo, Ahmed AlTurki, Fabio Stahlschmidt, Marcia Olandoski, Jean Rodrigo Tafarel, Dalton Bertolin Precoma. Nonalcoholic Fatty Liver Disease and Coronary Artery Disease: Big Brothers in Patients with Acute Coronary Syndrome. The Scientific World Journal 2020; 2020: 1 doi: 10.1155/2020/8489238
|